YANG MICHAEL J. — SEC insider filings

SEC reporting owner CIK 1702283. 18 insider filings on record with FilingPulse; latest filed 2026-11-17.

Transaction summary — filings shown

Covers all 18 filings on record, filed 2020-10-13 to 2026-11-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
ACADIA PHARMACEUTICALS INC (ACAD)EVP and CCO2—2 legs · 2,367 sh · $112,8134
Pacira BioSciences, Inc. (PCRX)Director61 leg · 2,000 sh · $25,800—13
IONIS PHARMACEUTICALS INC (IONS)Director9——14
AKCEA THERAPEUTICS, INC. (AKCA)Director1——1

Insider filings — YANG MICHAEL J.

FiledFormIssuerReported transactionsSource
2026-11-174Pacira BioSciences, Inc. (PCRX)Code (U): 13,393 @ $36.50 · Disposition to issuer (D): 6,405 @ $36.50 · Disposition to issuer (D): 12,179 (derivative) · Disposition to issuer (D): 11,279 (derivative) · Disposition to issuer (D): 10,891 (derivative) · Disposition to issuer (D): 30,967 (derivative)EDGAR
2026-07-064IONIS PHARMACEUTICALS INC (IONS)Grant/award (A): 5,369 (derivative) @ $0 · Grant/award (A): 2,301 (derivative) @ $0EDGAR
2026-06-124Pacira BioSciences, Inc. (PCRX)Grant/award (A): 6,405 @ $0 · Grant/award (A): 10,891 (derivative) @ $0EDGAR
2026-01-204IONIS PHARMACEUTICALS INC (IONS)Option exercise (M): 1,930 @ $0 · Option exercise (M): 1,930 (derivative) @ $0EDGAR
2025-07-174IONIS PHARMACEUTICALS INC (IONS)Option exercise (M): 4,079 @ $0 · Option exercise (M): 4,079 (derivative) @ $0EDGAR
2025-07-024IONIS PHARMACEUTICALS INC (IONS)Grant/award (A): 11,518 (derivative) @ $0 · Grant/award (A): 5,220 (derivative) @ $0EDGAR
2025-06-134Pacira BioSciences, Inc. (PCRX)Grant/award (A): 6,163 @ $0 · Grant/award (A): 11,279 (derivative) @ $0EDGAR
2025-01-174IONIS PHARMACEUTICALS INC (IONS)Option exercise (M): 1,931 @ $0 · Option exercise (M): 1,931 (derivative) @ $0EDGAR
2024-08-144Pacira BioSciences, Inc. (PCRX)Purchase (P): 2,000 @ $12.90EDGAR
2024-07-034/AIONIS PHARMACEUTICALS INC (IONS)Grant/award (A): 4,079 (derivative) @ $0EDGAR
2024-07-034IONIS PHARMACEUTICALS INC (IONS)Grant/award (A): 10,111 (derivative) @ $0EDGAR
2024-06-134Pacira BioSciences, Inc. (PCRX)Grant/award (A): 5,230 @ $0 · Grant/award (A): 12,179 (derivative) @ $0EDGAR
2024-01-174IONIS PHARMACEUTICALS INC (IONS)Grant/award (A): 5,791 (derivative) @ $0EDGAR
2023-12-184IONIS PHARMACEUTICALS INC (IONS)Grant/award (A): 12,356 (derivative) @ $0EDGAR
2023-10-114Pacira BioSciences, Inc. (PCRX)Grant/award (A): 30,967 (derivative) @ $0EDGAR
2021-01-084ACADIA PHARMACEUTICALS INC (ACAD)Option exercise (M): 2,722 · Sale (S): 1,120 @ $53.34 · Option exercise (M): 2,722 (derivative) @ $0EDGAR
2020-10-194ACADIA PHARMACEUTICALS INC (ACAD)Option exercise (M): 2,500 · Sale (S): 1,247 @ $42.56 · Option exercise (M): 2,500 (derivative) @ $0EDGAR
2020-10-134AKCEA THERAPEUTICS, INC. (AKCA)Disposition to issuer (D): 26,400 (derivative) @ $2.01EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1702283 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs